MoldCo is a healthcare technology platform that helps adults with chronic, non‑specific symptoms identify and treat mold exposure. It offers a free risk assessment, personalized treatment plans—including prescription binders, nasal spray, and peptide therapy—delivered to the patient’s home, and a symptom‑tracking dashboard with tele‑health support, all through a transparent subscription model.
Funding
$8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
1OCFFounders
Product
Problem
Many individuals experience chronic symptoms such as fatigue, brain fog, sinus issues, and hormonal changes, yet struggle to identify mold exposure as the underlying cause because standard medical testing often overlooks environmental factors.
Solution
MoldCo offers a technology‑enabled care pathway that connects patients with a network of mold‑trained providers, laboratory testing, and a patented, research‑backed treatment protocol. Users begin with a free risk assessment questionnaire to gauge potential mold exposure, then receive a personalized plan that includes prescription binders, EDTA nasal spray, and VIP peptide therapy delivered to their door. The platform provides a symptom‑tracking dashboard, messaging with the care team, and ongoing clinical support to monitor progress and adjust treatment phases. By bundling diagnostics, prescriptions, and tele‑health coordination, MoldCo streamlines mold recovery while keeping costs far below traditional specialist programs.
Target Audience
Primary customers are adults experiencing chronic, non‑specific health symptoms who suspect mold exposure, as well as health‑conscious individuals seeking an affordable, guided recovery program.
Features
- Free 3‑minute mold exposure risk questionnaire to identify potential environmental triggers
- Personalized, phased treatment protocol (binders, EDTA nasal spray, VIP peptide) prescribed by licensed providers
- Prescription medications shipped directly to the patient’s home
- Integrated symptom‑tracking dashboard and secure messaging with the care team
- Access to a network of CLIA‑certified labs and specialized clinicians for consultations and lab testing
- Transparent, subscription‑based pricing model with monthly plans ranging from $79 to $313
- HSA/FSA‑eligible payments and itemized fee breakdown available on request